These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7957499)

  • 1. Apolipoproteins and coronary heart disease.
    Schaefer EJ
    Eur J Clin Invest; 1994 Jul; 24(7):441-3. PubMed ID: 7957499
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative contribution of lipids and apolipoproteins to incident coronary heart disease and ischemic stroke: the PRIME Study.
    Canouï-Poitrine F; Luc G; Bard JM; Ferrieres J; Yarnell J; Arveiler D; Morange P; Kee F; Evans A; Amouyel P; Ducimetiere P; Empana JP;
    Cerebrovasc Dis; 2010 Aug; 30(3):252-9. PubMed ID: 20664258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New diagnostic tests for assessing coronary heart disease risk.
    Naito HK
    Prog Clin Biol Res; 1988; 255():49-62. PubMed ID: 3277204
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein measurements--setting priorities.
    Wilson PW
    Am J Med; 2001 Jan; 110(1):71-2. PubMed ID: 11152872
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of age and cigarette smoking on serum concentrations of lipids and apolipoproteins in a male military population.
    Cuesta C; Sánchez-Muniz FJ; García-La Cuesta A; Garrido R; Castro A; San-Felix B; Domingo A
    Atherosclerosis; 1989 Nov; 80(1):33-9. PubMed ID: 2604755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
    Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipids and apolipoproteins in relation to the degree of coronary sclerosis].
    Herrmann W; Hanf S; Schütz C; Lindhofer HG; Abe I; Strauss HJ; Schmidt H; Schaedel H; Reuter W
    Z Gesamte Inn Med; 1986 Feb; 41(4):98-102. PubMed ID: 3705656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein(a) is a potential coronary risk factor.
    Fujino A; Watanabe T; Kunii H; Yamaguchi N; Yoshinari K; Watanabe Y; Mutou M; Ishikawa S; Ogyuu A; Ashikawa K; Maruyama Y
    Jpn Circ J; 2000 Jan; 64(1):51-6. PubMed ID: 10651207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in coronary artery disease risk-factor research: what remains to be done?
    Crouse JR
    Clin Chem; 1984 Jul; 30(7):1125-7. PubMed ID: 6428775
    [No Abstract]   [Full Text] [Related]  

  • 11. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
    Barter P; Gotto AM; LaRosa JC; Maroni J; Szarek M; Grundy SM; Kastelein JJ; Bittner V; Fruchart JC;
    N Engl J Med; 2007 Sep; 357(13):1301-10. PubMed ID: 17898099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse cholestrol transport substantially influences the individual risk of coronary heart disease in hypercholesterolaemic patients.
    Poledne R; Rosolová H
    Eur Heart J; 2001 Mar; 22(6):442-3. PubMed ID: 11237535
    [No Abstract]   [Full Text] [Related]  

  • 13. High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.
    Barbir M; Wile D; Trayner I; Aber VR; Thompson GR
    Br Heart J; 1988 Nov; 60(5):397-403. PubMed ID: 3203033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High density lipoproteins and coronary heart disease.
    Barter PJ
    Aust N Z J Med; 1991 Jun; 21(3):299-301. PubMed ID: 1953506
    [No Abstract]   [Full Text] [Related]  

  • 15. Study on cholesteryl ester transfer activity in coronary heart disease.
    Fujinuma Y; Tanaka A; Maezawa H
    Bull Tokyo Med Dent Univ; 1991 Sep; 38(3):27-33. PubMed ID: 1934199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic heart disease, serum cholesterol, and apolipoproteins in CAPD.
    Gault MH; Longerich L; Prabhakaran V; Purchase L
    ASAIO Trans; 1991; 37(3):M513-4. PubMed ID: 1751258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease.
    Biswas S; Ghoshal PK; Mandal SC; Mandal N
    J Cardiol; 2008 Oct; 52(2):118-26. PubMed ID: 18922385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of serum lipids, lipoproteins, and apolipoproteins with coronary artery disease assessed by coronary arteriography.
    Naito HK
    Ann N Y Acad Sci; 1985; 454():230-8. PubMed ID: 3865610
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein and apoprotein A1 levels in diabetics and coronary heart disease patients and controls.
    Pan XR; Hu SX; Gang Y; Jin L; Li XG; Li J; Yan Q; Chen TS
    Chin Med J (Engl); 1987 Mar; 100(3):204-7. PubMed ID: 3113842
    [No Abstract]   [Full Text] [Related]  

  • 20. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.